Pig models open new window into albinism research

A pig's eye is, in several measurable ways, closer to a human eye than a mouse's. That structural similarity is at the centre of a study published in Nature, in which researchers generated pig models of oculocutaneous albinism type 1 (OCA1) using selection-free genome editing.

OCA1 is caused by mutations in the TYR gene, which encodes the enzyme tyrosinase. The condition affects melanin production in the skin, hair, and eyes, and is associated with reduced visual acuity, nystagmus, and foveal hypoplasia. The study reported that existing mouse models of OCA1 do not replicate the full range of eye development seen in humans — a gap the pig model was designed to address.

The researchers used genome editing to introduce TYR mutations into pig embryos without relying on antibiotic selection markers, a method the study described as selection-free. The resulting animals displayed the expected pigmentation phenotype: white coats and pink eyes. Ophthalmological characterisation confirmed structural changes in the eye consistent with OCA1, the study found.

Why the pig model matters

The pig retina contains a region analogous to the human fovea — the small central area of the eye responsible for sharp, detailed vision. According to the study, this makes pigs a more representative model for examining the visual pathway abnormalities that accompany albinism, including the misrouting of optic nerve fibres that contributes to reduced stereoscopic vision.

Researchers reported that foveal hypoplasia — underdevelopment of this central retinal region — could be examined in the pig model in ways not previously possible in rodent studies. That specificity matters: foveal hypoplasia is one of the primary reasons that people with OCA1 often experience significantly reduced visual acuity from birth, and it currently has no approved treatment.

The selection-free editing method was also noted as a technical advance. Removing the need for selection markers simplifies the process of creating genetically precise animal models and reduces the risk of unintended genomic changes, the study said.

The work was published in Nature and adds to a small but growing body of research using large-animal models to study pigmentation disorders with complex visual components.

For the albinism community, this research sits upstream of clinical application — its value lies in building more accurate tools for understanding a condition that affects an estimated 1 in 17,000 people globally, according to the National Organization for Albinism and Hypopigmentation. The gap between a more faithful animal model and a therapy is wide, and the study makes no claims about treatment timelines.

What it does offer is a sharper instrument for asking questions that have, until now, been difficult to answer with precision.